Related Experiment Video
Updated: May 8, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah
Chris Stockmann1, Krow Ampofo, Carrie L Byington
1Division of Pediatric Infectious Diseases, University of Utah Health Sciences Center, Salt Lake City, UT 84108, USA. chris.stockmann@hsc.utah.edu
Insights
Pediatric pneumococcal meningitis remains a significant threat, with similar death and disability rates from both vaccine and non-vaccine serotypes. Continued immunization and surveillance are crucial.
Area of Science:
- Pediatric infectious diseases
- Vaccinology
- Epidemiology
Background:
- The 7-valent pneumococcal conjugate vaccine (PCV7) significantly reduced pediatric pneumococcal meningitis incidence in the US.
- However, cases persist, raising questions about the comparative impact of PCV7 versus non-PCV7 serotypes on disease severity.
Purpose of the Study:
- To compare the morbidity and mortality associated with pneumococcal meningitis caused by PCV7 and non-PCV7 serotypes in children.
- To assess the long-term neurologic sequelae in survivors.
Main Methods:
- A retrospective cohort study of laboratory-confirmed pneumococcal meningitis cases in Utah children (1997-2010).
- Review of medical records for clinical data and follow-up on neurologic sequelae.
Main Results:
- PCV7 serotypes decreased from 64% to 25% post-vaccine licensure (P < .01).
- Overall case fatality rate was 13%, with no significant difference between PCV7 and non-PCV7 serotypes (P = .7).
- Children with PCV7 serotype meningitis were more likely to require mechanical ventilation (68% vs 34%; P < .01), and 63% of survivors had neurologic sequelae, similar for both serotype groups (P = .1).
Conclusions:
- Pneumococcal meningitis continues to cause high mortality and morbidity, regardless of serotype.
- Neurologic sequelae are common in survivors of both PCV7 and non-PCV7 serotype meningitis.
- The ongoing disease burden highlights the need for enhanced immunization strategies and surveillance, especially with the advent of PCV13.
Background:
After licensure of the 7-valent pneumococcal conjugate vaccine (PCV7) in the United States in 2000, the incidence of pediatric pneumococcal meningitis decreased significantly. However, cases continue to occur. It is unknown whether meningitis due to PCV7 and non-PCV7 serotypes causes similar morbidity and mortality.
Methods:
We performed a retrospective cohort study of laboratory-confirmed pneumococcal meningitis among Utah children from 1997 to 2010. We reviewed medical records and obtained clinical data during the acute illness and follow-up data on neurologic sequelae.
Results:
Sixty-eight cases of meningitis were identified. PCV7 serotypes caused 64% of cases before and 25% of cases after licensure of PCV7 (P < .01). The age range was similar before and after PCV7 licensure (P = .5). The overall case fatality rate was 13% and was similar among cases caused by PCV7 and non-PCV7 serotypes (P = .7). Children with PCV7 serotypes were more likely to require mechanical ventilation (68% vs 34%; P < .01). Of all survivors, 63% had neurologic sequelae, and the proportion was similar after infection with PCV7 or non-PCV7 serotypes (P = .1). More than one-half (54%) of all children who developed pneumococcal meningitis in the PCV7 period were eligible for PCV7 and had not been immunized.
Conclusions:
Pneumococcal meningitis continues to be associated with high mortality and morbidity; death and neurologic sequelae are common with both PCV7 and non-PCV7 serotype meningitis. The substantial burden of this disease and continued cases among unimmunized children reinforce the need for more effective immunization strategies and continued surveillance in the era of PCV13.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Bacterial Meningitis I: Introduction
Atypical Pneumonia
Bacterial Meningitis II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.

